Literature DB >> 20125163

DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy.

In-Hyun Park1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125163      PMCID: PMC2839312          DOI: 10.1038/mt.2009.303

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  25 in total

Review 1.  The emerging biology of satellite cells and their therapeutic potential.

Authors:  Shihuan Kuang; Michael A Rudnicki
Journal:  Trends Mol Med       Date:  2008-01-22       Impact factor: 11.951

2.  Functional skeletal muscle regeneration from differentiating embryonic stem cells.

Authors:  Radbod Darabi; Kimberly Gehlbach; Robert M Bachoo; Shwetha Kamath; Mitsujiro Osawa; Kristine E Kamm; Michael Kyba; Rita C R Perlingeiro
Journal:  Nat Med       Date:  2008-01-20       Impact factor: 53.440

Review 3.  Progress in myoblast transplantation: a potential treatment of dystrophies.

Authors:  D Skuk; J P Tremblay
Journal:  Microsc Res Tech       Date:  2000 Feb 1-15       Impact factor: 2.769

4.  Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells.

Authors:  Hidetoshi Sakurai; Yayoi Okawa; Yuta Inami; Naomi Nishio; Ken-ichi Isobe
Journal:  Stem Cells       Date:  2008-05-01       Impact factor: 6.277

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

Review 6.  The promise of human induced pluripotent stem cells for research and therapy.

Authors:  Shin-ichi Nishikawa; Robert A Goldstein; Concepcion R Nierras
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

7.  Generation of mouse induced pluripotent stem cells without viral vectors.

Authors:  Keisuke Okita; Masato Nakagawa; Hong Hyenjong; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Science       Date:  2008-10-09       Impact factor: 47.728

8.  Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.

Authors:  Rachid Benchaouir; Mirella Meregalli; Andrea Farini; Giuseppe D'Antona; Marzia Belicchi; Aurélie Goyenvalle; Maurizio Battistelli; Nereo Bresolin; Roberto Bottinelli; Luis Garcia; Yvan Torrente
Journal:  Cell Stem Cell       Date:  2007-12-13       Impact factor: 24.633

Review 9.  Myoblast transplantation: the current status of a potential therapeutic tool for myopathies.

Authors:  Daniel Skuk; Jacques P Tremblay
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

10.  Myogenic specification of side population cells in skeletal muscle.

Authors:  Atsushi Asakura; Patrick Seale; Adele Girgis-Gabardo; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2002-10-14       Impact factor: 10.539

View more
  1 in total

Review 1.  Cellular reprogramming: a new technology frontier in pharmaceutical research.

Authors:  Amy Brock; Hui-Tong Goh; Binxia Yang; Yu Lu; Hu Li; Yuin-Han Loh
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.